Skip to main content

Table 1 Antibiotic resistance results of isolated pathogens

From: Intracellular bacterial communities in patient with recurrent urinary tract infection caused by Staphylococcus spp and Streptococcus agalactiae: a case report and literature review

Antibiotic

SA 1

SA 2

SE 1

SE 2

SS 1

SS 2

SGB 1

SGB 2

AMC

S

R

R

R

R

R

S

S

AMS

S

R

R

R

R

R

S

S

AMP

R

R

R

R

R

R

S

S

CRO

S

R

R

R

R

R

S

S

CIP

R

R

R

R

R

R

R

R

CLI

R

R

R

R

R

R

R

R

CX

S

R

ND

ND

ND

ND

ND

ND

DAP

S

S

S

S

S

S

S

S

ERY

R

R

R

R

R

R

R

R

GM

S

S

S

R

S

S

S

R

LEV

R

S

R

R

R

R

R

R

LNZ

S

S

S

S

S

S

S

S

MOX

R

S

R

R

R

R

R

S

NIT

S

S

S

S

S

S

S

S

OXA

R

R

ND

ND

ND

ND

ND

ND

PEN

R

R

R

R

R

R

S

S

RIF

S

S

S

S

S

S

S

S

SYN

S

R

S

S

S

S

S

S

TET

S

S

S

S

S

S

S

S

SXT

S

S

S

S

S

S

S

S

VAN

S

S

S

S

S

S

S

S

  1. AMC Amoxicillin/Clavulanic acid, AMS Ampicillin/Sulbactam, AMP Ampicillin, CRO Ceftriaxone, CIP Ciprofloxacin, CLI Clindamycin, DAP Daptomycin, ERY Erythromycin, GM Gentamicin, LEV Levofloxacin, LNZ Linezolid, MOX Moxifloxacin, NIT Nitrofurantoin, OXA Oxacillin, PEN Penicillin, RIF Rifampicin, SYN Synercid, TET Tetracycline, SXT Cotrimoxazole, VAN Vancomycin, SA Staphylococcus aureus, SE Staphylococcus epidermidis, SS Staphylococcus simulans, SGB Streptococcus agalactiae, R Resistant, S Sensible, ND Not determined